Trial intelligence / Profile preview

Pre-colonoscopy Movicol to reduce Moviprep dose in chronic constipation

jRCT1061210085Recruiting

Start
Jul 2022
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Randomised trial of polyethylene glycol in chronic constipation (2 arms). Primary endpoint: The amount of Moviprep drunk for intestinal lavage. Started Jul 2022; status: recruiting.

02

Drugs

polyethylene glycol
03

Conditions

chronic constipation

Beyond the preview

Go deeper on jRCT1061210085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1061210085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call